Movement Disorders and Neuromodulation Center

Parkinson's Disease Clinical Trials (Enrolling)

PD GENEration: Mapping the Future of Parkinson's Disease
Principal Investigator: Jill Ostrem, MD
Study Contact: Aaron Daley, aaron.daley@ucsf.edu and Aiko De Arth, aiko.dearth@ucsf.edu

Understanding Motivation in Parkinson's Patients Through Neurophysiology
Principal Investigator: Simon Little, MBBS, PhD
Study Contact: Jiyeon.Suh, Jiyeon.Suh@ucsf.edu

The Parkinson's Progression Markers Initiative (PPMI) 2.0 Clinical -Establishing a Deeply Phenotyped PD Cohort
Principal Investigator: Caroline Tanner, MD, PhD
Study Contact: Farah.Kausar, PhD, Farah.Kausar@ucsf.edu

Parkinson Progression Marker Initiative Online (PPMI Online)
Principal Investigator: Caroline Tanner, MD, PhD
Study Contact: info@ppmionline.org

A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease (PADOVA)
Principal Investigator: Caroline Tanner, MD, PhD
Study Contact: Farah.Kausar, PhD, Farah.Kausar@ucsf.edu

Study in Parkinson Disease of Exercise Phase 3 Clinical Trial: SPARX3
Principal Investigator: Caroline Tanner, MD, PhD
Study Contact: Corinna Conroy, Corinna.Conroy@ucsf.edu

TOPAZ: Trial of Parkinson's And Zoledronic Acid A Randomized Placebo-controlled Trial of Zoledronic Acid for the Prevention of Fractures in Patients With Parkinson's Disease
Principal Investigator: Caroline Tanner, MD, PhD
Study Contact: Jacque Perkins, Jacque.Perkins@ucsf.edu

Advanced Magnetic Resonance Imaging for Deep Brain Stimulation Therapy
Principal Investigator: Melanie Morrison, PhD
Study Contact: Sarah Wang, PhD, Sarah.Wang@ucsf.edu

Globus pallidus interna (GPi) deep brain stimulation (DBS) for Parkinson’s Disease (PD): Impact on sleep disorders
Principal Investigator: Rafael Zuzuarregui, MD
Study Contact: Allisun Wiltshire, Allisun.Wiltshire@uscf.edu

A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants With Parkinson's Disease
Principal Investigator: Marta San Luciano, MD, MS
Study Contact: Allisun Wiltshire, Allisun.Wiltshire@ucsf.edu

Subgaleal cortical recordings in patients with Parkinson's disease undergoing Deep Brain Stimulation Therapy
Principal Investigator: Philip Starr, MD, PhD
Study Contact: Stephanie Sandoval-Pistorius, Stephanie.SandovalPistorius@ucsf.edu

Determining the circuits and signals of sleep dysfunction in Parkinson's disease through chronic overnight recordings and sleep-specific Deep Brain Stimulation
Principal Investigator: Simon Little, MBBS, PhD
Study Contact: Jiyeon.Suh, Jiyeon.Suh@ucsf.edu

Multicenter Investigation of Psychometric Properties of Measures used in Neuropsychological Evaluations in Parkinson's diseaese
Principal Investigator: Deborah Cahn-Weiner

Psilocybin Therapy for Depression in Parkinson's Disease (PDP2)
Principal Investigator: Joshua Woolley, MD, PhD
Study Contact: Brigette Sosa, pdp2@ucsf.edu

A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)
Principal Investigator: Chad Christine, MD
Study Contact: Aaron Daley, Aaron.Daley@ucsf.edu

Exercise for Cognitive Excellence in Parkinson's Disease
Principal Investigator: Nijee Luthra, MD, PhD
Study Contact: Corinna Conroy, Corinna.Conroy@ucsf.edu